Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Investig Drugs. 2008 Aug;9(8):899-912.

Rilpivirine, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection.

Author information

1
Malattie Infettive, Ospedali Riuniti di Bergamo, Largo Barozzi 1, 24128 Bergamo, Italy. diego.ripamonti@hotmail.com

Abstract

Tibotec BVBA is developing the diarylpyrimidine rilpivirine, a second-generation non-nucleoside reverse transcriptase inhibitor for the potential treatment of HIV infection. A phase III trial of rilpivirine in HIV-infected, treatment-naive indivuduals is underway and is to be completed by August 2010.

PMID:
18666038
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center